Prostaglandin-stimulated adenylyl cyclase activity via a pharmacologically defined EP2 receptor in human nonpigmented ciliary epithelial cells

Journal of Ocular Pharmacology and Therapeutics

Volumn 14, Issue 4, 1998, Pages 293-304

  Crider, J Y ^a   Griffin, B W ^a   Sharif, N A ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 DEOXY 13,14 DIDEHYDRO 16 METHYLPROSTAGLANDIN E2 METHYL ESTER; 11 DEOXY 16 PHENOXY 17,18,19,20 TETRANORPROSTAGLANDIN E1; 16,16 DIMETHYLPROSTAGLANDIN E2 METHYL ESTER; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; ADENYLATE CYCLASE; CYCLIC AMP; PROSTACYCLIN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E1; PROSTAGLANDIN E1 DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN E2 DERIVATIVE; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE;

ANIMAL CELL; AQUEOUS HUMOR FLOW; CATTLE; CILIARY BODY EPITHELIUM; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; HUMAN CELL; NONHUMAN; PROSTAGLANDIN SYNTHESIS; RADIOIMMUNOASSAY; RECEPTOR UPREGULATION;

EID: 0031848139     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1998.14.293     Document Type: Conference Paper

References (45)

1. Crider, J.Y., Griffin, B.W., Xu. S.X. and Sharif, N.A. Use of a semi-automated radioimmunoassay to measure cAMP generated by activation of prostaglandin receptors in human ocular and other cell types. Pros. Leuko. Essen. Fatty Acids. In press.
2. Kennedy, I., Coleman, R.A., Humphrey, P.P.A., Levy, G.P., and Lumley, P. Studies on the characterization of prostanoid receptors: a proposed classification. Prostaglandins 24:667-689, 1982.
3. Coleman, R.A., Humphrey, P.P.A., Kennedy, I., and Lumley, P. Prostanoid receptors: The development of a working classification. Trends Pharmacol. Sci. 5:303-306, 1984.
4. Coleman, R.A., Smith, W.L., and Narumiya, S. VIII. International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46:205-229, 1994.
5. Smith, W.L. The eicosanoids and their biochemical mechanisms of action. Biochem. J. 259:315-324, 1989.
6. 2α-1-isopropylester in the cynomologus monkey. Exp. Eye Res. 48:707-716, 1989.
7. Alm, A. and Villmusen, J. PhXA34, a new potent ocular hypotensive drug: A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers. Arch. Ophthalmol. 109:1564-1568, 1991.
8. Goh, Y., Hotehama, Y., and Mishima, H.K. Characterization of ciliary muscle relaxation induced by various agents in cats. Invest. Ophthalmol. Vis. Sci. 36(6):1188-1192, 1995.
9. Bhattacherjee, P., Rhodes, L., and Paterson, C. Prostaglandin receptors coupled to adenylyl cyclase in the iris-ciliary body of rabbits, cats and cows. Exp. Eye Res. 56:327-333, 1993.
10. Ohia, S.E. and Jumblatt, J.E. Prejunctional inhibitory effects of prostanoids on sympathetic neurotransmission in the rabbit iris-ciliary. J. Pharmacol. Exp. Ther. 255:11-16, 1990.
11. Ohia, S.E. and Jumblatt, J.E. Prejunctional prostaglandin receptors in the human iris-ciliary body. Curr. Eye Res. 10:967-975, 1991.
12. 2-receptor stimulated cyclic amp synthesis in cultured human non-pigmented ciliary epithelium. Exp. Eye Res. 58:563-566, 1994.
13. Sharif, N.A., Crider, J.Y., Griffin, B.W., Devis, T.L., and Howe, W.E. Pharmacological analysis of mast cell mediator and neurotransmitter receptors coupled to adenylate cyclase and phospholipase C on immunocytochemically-defined human conjunctival epithelial cells. J. Ocular Pharmacol. Ther. 13:321-336, 1997.
14. 1Dβ receptor. Mol. Pharmacol. 41:1-7, 1992.
15. Michel, A.D. and Whiting, R.L. Analysis of ligand binding data using a microcomputer. Br. J. Pharmacol., 83:460P, 1984.
16. 3H]GR65630 binding. Br. J. Pharmacol. 102:919-925, 1991.
17. Griffin, B.W., Williams, G.W., Crider, J.Y., and Sharif, N.A. FP prostaglandin receptors mediating inositol phosphate generation and calcium mobilization in Swiss 3T3 cells: A pharmacological study. J. Pharmacol. Exp. Ther. 281:845-854, 1997.
18. Kiriyama, M., Ushikubi, F., Kobayashi, T., Hirata, M., Sugimoto, Y., and Narumiya, S. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br. J. Pharmacol. 122:217-224, 1997.
19. 2α binding sites in the bovine iris ciliary body. Invest. Ophthalmol. Vis. Sci. 34:2237-2245, 1993.
20. Boie, Y., Rino, S., Sawyer, N., Slipetz, D.M., Ungrin, M., Neuschäfer-Rube, F., Püschel, G., Metters, K.M., and Abramovitz, M. Cloning and characterization of the four rat EP prostanoid receptor subtypes. FASEB J. 11:A 1138, 1997.
21. 2 subtype. Mol. Pharmacol. 46:213-220, 1994.
22. 4, and FP receptors in human ciliary epithelial and ciliary muscle cells. Biochem. Pharmacol. 53:1249-1255, 1997.
23. 4 receptors positively coupled to adenylate cyclase. Br. J. Pharmacol. 113 Proc.Suppl. 8P, 1994.
24. 4 subtype. FEBS Letters. 364: 339-341, 1995.
25. Bhattacherjee, P., Jacobs., N., Coca-Prados, M., and Paterson, C. Identification of prostanoid receptors in rabbit non-pigmented ciliary epithelial cells. Exp. Eye Res. 62:491-498, 1996.
26. 2 receptor antagonist. Biochem. Pharmacol. 50:1731-1733, 1995.
27. 2-responsive cell line from bovine embryonic trachea. Br. J. Pharmacol. 99:13-14, 1990.
28. Keery, R.J. and Lumley, P. AH6809, a prostaglandin DP-receptor blocking drug on human platelets. Br. J. Pharmacol. 94:745-754, 1988.
29. Coleman, R.A., Kennedy, I., Humphrey, P.P.A., Buncea, K., and Lumley, P. Prostanoids and their receptors. In: Comprehensive Medicinal Chemistry (Ed. Emmett, JC), Vol. 3, Pergamon Press, New York, 1990, pp. 643-714.
30. 2 in primary cultures of bovine adrenal medullary cells: Identification of the responsive population as fibroblasts. Biochim. Biophys. Acta 1011:75-80, 1989.
31. Blair, I.A., Hensby, C.M., and MacDermot, J. Prostacyclin-dependent activation of adenylate cyclase in a neuronal somatic cell hybrid: Prostanoid structure-activity relationships. Br. J. Pharmacol. 69:519-525, 1980.
32. Wilkins, A.J. and MacDermot, J. The putative prostacyclin receptor antagonist (FCE-22176) is a full agonist on human platelets and NCB-20 cells. Eur. J. Pharmacol. 127:117-119, 1986.
33. Yousufzai, S.Y.K., Chen, A.-L., and Abdel-Latif, A.A. Species differences in the effects of prostaglandins on inositol trisphosphate accumulation, phosphatidic acid formation, myosin light chain phosphorylation and contractions in iris sphincter of the mammalian eye: Interaction with the cyclic AMP system. J. Pharmacol. Exp. Ther. 247:1064-1072, 1988.
34. 2 binding site distribution and subtype classification in the rabbit iris-ciliary body. Prostaglandins 44:199-208, 1992.
35. 2 receptor subtypes in porcine ocular tissues. II. Nonuveal tissues. J. Ocular Pharmacol. Ther. 11:437-445, 1995.
36. 2 receptor in porcine ciliary epithelium. J. Ocular Pharmacol. 10(1):157-166, 1994.
37. 2 on porcine ciliary muscle cells in culture. Curr. Eye Res., 14(12):1155-1163, 1995.
38. 2 receptor is the predominant prostanoid receptor in the human ciliary muscle. Br. J. Ophthalmol. 77(2):110-114, 1993.
39. 2, FP or TP prostanoid-receptor stimulation may reduce intraocular pressure. Invest. Ophthalmol. Vis. Sci. 31:2560-2567, 1990.
40. DeSantis, L.I. and Sallee, V.I. Comparison of the effects of prostaglandins and their esters on blood-aqueous barrier integrity and intraocular pressure in rabbits. In: The Ocular Effects of Prostaglandins and Other Eicosanoids. Bito, L.Z. and Stjernschantz, J. (Eds.). Alan Liss, Inc.: New York, 1989, pp. 379-386.
41. 2 receptor subtype. Invest. Ophthalmol. Vis. Sci. 31:2463-2466, 1990.
42. Bito, L.Z., Camras, C.B., Gum, G.G., and Resul, B. The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals. In: The Ocular Effects of Prostaglandins and Other Eicosanoids. Bito, L.Z. and Stjernschantz, J. (Eds.). Alan Liss, Inc., New York, 1989, pp. 349-368.
43. 2α or epinephrine on cynomolgus monkey eyes. I. Aqueous humor dynamics. Invest. Ophthalmol. Vis. Sci. 28:463-469, 1987.
44. 2α. Arch. Ophthalmol. 105:1112-1115, 1987.
45. 2 receptor. J. Ocular Pharmacol. Ther. 11:447-454, 1995.